Skip to main content
Figure 3 | Journal of Inflammation

Figure 3

From: Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis

Figure 3

Anti-IL-6 inhibited disease progression. DBA/1 LacJ mice were dosed with anti-IL-6 antibody (1 mg or 5 mg/mouse) or irrelevant control antibody (1 mg/mouse) two days prior to injection with collagen and weekly for 10 weeks. Bars represent number of involved paws (mean ± SEM) in each mouse at the end of the study (day 70). Statistical differences between the groups were determined using ANOVA (SPSS Inc, Chicago, IL).

Back to article page